Achieve Life Sciences QUIT

Achieve Life Sciences, now doing business as AchieveRx, is a late-stage drug company focused on nicotine dependence. Its only product candidate is cytisinicline, an oral tablet for quitting smoking and vaping, which has two completed Phase 3 trials. It has no revenue yet and funds itself by selling shares and warrants while it prepares to resubmit its FDA application and launch in the US.